Bio Therapy
A MESSAGE FROM THE CHIEF
ALZHEIMER IMMUNOTHERAPY Debarge Valentin Fontaine Quentin Olivier Jérôme $1,5 billion : a good investment? 02-2009.
Advances in immunotherapy for lymphomas and myeloma
Inovio Pharmaceuticals, Inc. - Corporate Presentation
Inovio - Revolutionizing the Fight Against Cancers and Infectious Diseases
Pp 150130 inovio bio ceo final
Inovio - Corporate Presentation
Revolutionizing the Fight Against Cancers and Infectious Diseases
CORPORATE OVERVIEW TNIB is a late stage immunotherapy company with short term sustainable revenue delivering low cost, effective, safe immuno therapies.
